戻る Agenda
What's New in Health Canada: Updates and New Endeavors
Session Chair(s)
Agnes Klein, MD
Senior Medical Advisor
Health Canada, Canada
This froum will discuss the new approaches Health Canada proposes to take in making drugs necessary to the healthcare system available earlier and in a more streamlined fashion. This is also an opportunity to strengthen older endeavors.
Learning Objective : Discuss approaches that Health Canada is intending to take in modernizing how the regulatory programs are delivered so that they are harmonized and convergent with international endeavors.
Speaker(s)
Improving Access to Necessary Therapeutic Products in Canada
Michèle Chadwick, MBA
Health Canada, Canada
Lead, Regulatory Review of Drugs and Devices, HPFB
Updates on Biosimilars
Agnes Klein, MD
Health Canada, Canada
Senior Medical Advisor
Regulator Perspective on the Opioid Crisis
Marilena Bassi, MA
Health Canada, Canada
Senior Executive Director, Therapeutic Products Directorate